文献速递流行病学与生物统计临床试验与 GCP基础与转化研究

GNE肌病疾病进展的贝叶斯模型

Bayesian model of disease progression in GNE myopathy.
PubMed 文献 · Stat Med · 2018-12-03

本研究基于一项前瞻性自然史研究收集的纵向定量肌力数据,构建贝叶斯潜变量重复测量模型以刻画GNE肌病的疾病进展。模型生成的「疾病年龄」与多种临床、功能和患者报告结局高度相关;在模型中引入治疗效应参数后提出的疾病修饰分析,与传统分析方法相比可显著提高检验效能并减少所需受试者人数。

要点

  • 贝叶斯潜变量重复测量模型可基于纵向定量肌力数据刻画GNE肌病进展。
  • 模型生成的「疾病年龄」与多种临床、功能和患者报告结局高度相关。
  • 引入治疗效应参数的疾病修饰分析可提高效能并减少所需受试者数。

核心结论

  • 基于前瞻性自然史研究纵向定量肌力数据构建的贝叶斯潜变量重复测量模型可刻画GNE肌病的疾病进展,其生成的「疾病年龄」与多种临床、功能和患者报告结局高度相关。
  • 在模型中引入治疗效应参数后提出的GNE肌病疾病修饰分析,与传统分析方法相比可显著提高检验效能并减少所需受试者人数。

研究设计与样本

  • 研究基于一项前瞻性自然史研究收集的纵向定量肌力数据,构建贝叶斯潜变量重复测量模型以确定GNE肌病的疾病进展。

主要发现

  • GNE肌病进展模型提供了原本需要不可行时长的自然史研究才能获得的疾病进展认识。
  • 「疾病年龄」这一模型生成的疾病进展指标与多种临床、功能和患者报告结局高度相关。
  • 引入治疗效应参数后的疾病修饰分析可显著提高检验效能并减少检验新疗法有效性所需的受试者人数。

临床怎么用

  • 该进展模型与疾病修饰分析可用于具有前瞻性肌力数据的肌肉疾病,以及多种罕见且缓慢进展的疾病,用于临床试验设计与疗效检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

One Sentence Summary: A Bayesian repeated measures model based on quantitative muscle strength data from a prospective Natural History Study was developed to determine disease progression and design clinical trials for GNE myopathy, a rare and slowly progressive muscle disease. GNE myopathy is a rare muscle disease characterized by slowly progressive weakness and atrophy of skeletal muscles. To address the significant challenges of defining the natural history and designing clinical trials for GNE myopathy, we developed a Bayesian latent variable repeated measures model to determine disease progression. The model is based on longitudinal quantitative muscle strength data collected as part of a prospective Natural History Study. The GNE Myopathy Progression Model provides an understanding of disease progression that would have otherwise required a natural history of unfeasible duration. "Disease age," the model-generated measure of disease progression, highly correlates with a variety of clinical, functional and patient-reported outcomes. With the incorporation of a treatment effect parameter to the GNE Disease Progression Model, we describe a novel GNE Myopathy Disease Modification Analysis that significantly increases power and reduces the number of subjects required to test the effectiveness of novel therapies when compared to more traditional analysis methods. The GNE Myopathy Disease Progression Model and Disease Modification Analysis can be applied to muscle diseases with prospectively collected muscle strength data, and a variety of rare and slowly progressive diseases.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Quintana M, Shrader J, Slota C, et al. Bayesian model of disease progression in GNE myopathy. Stat Med. 2018. PMID: 30511500. doi:10.1002/sim.8050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。